Search

everythinglearnresearchcommunity

for

Search:↓

Particulate matter causes inflammation in hair cells, potentially harming hair growth.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

Baricitinib is effective for severe alopecia areata but has some side effects.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Ruxolitinib helped regrow hair in a woman with a blood disorder and complete hair loss.

Leflunomide is more likely to help treat alopecia areata than cause it.

Certain immune cells in the skin can stop hair from growing.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Tofacitinib helped a woman regrow hair with no major side effects.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

Baricitinib may effectively treat nail changes in alopecia areata.

Oclacitinib effectively treated a diabetic cat's severe skin issues without raising glucose levels, and surgery fixed eyelid fusion.

More precise, personalized therapies are needed for autoimmune diseases.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

Similar treatments might work for different types of scarring hair loss.